Cells exposed to sublethal oxidative stress selectively attract monocytes/macrophages via scavenger receptors and MyD88-mediated signaling

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1234-1244

  Geiger Maor, Anat ^a   Levi, Inbar ^a   Even Ram, Sharona ^a   Smith, Yoav ^b   Bowdish, Dawn M ^c   Nussbaum, Gabriel ^a   Rachmilewitz, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CD14 ANTIGEN; DEXTRAN SULFATE; FUCOIDIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MALONALDEHYDE; MYELOID DIFFERENTIATION FACTOR 88; SCAVENGER RECEPTOR;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIMERIZATION; ENZYME ACTIVITY; FIBROBLAST; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD14; CELL MOVEMENT; FIBROBLASTS; HUMANS; MACROPHAGES; MICE; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; OXIDATIVE STRESS; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION;

EID: 84856585193     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101740     Document Type: Article

References (57)

1. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12: 991-1045. (Pubitemid 24140436)
2. van der Most, R. G., A. J. Currie, B. W. Robinson, and R. A. Lake. 2008. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. Cell Death Differ. 15: 13-20. (Pubitemid 350286168)
3. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8: 279-289. (Pubitemid 351432799)
4. Rock, K. L., and H. Kono. 2008. The inflammatory response to cell death. Annu. Rev. Pathol. 3: 99-126. (Pubitemid 351488277)
5. Gallucci, S., and P. Matzinger. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13: 114-119. (Pubitemid 32096970)
6. Skoberne, M., A. S. Beignon, and N. Bhardwaj. 2004. Danger signals: a time and space continuum. Trends Mol. Med. 10: 251-257. (Pubitemid 38725891)
7. Bianchi, M. E. 2007. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81: 1-5. (Pubitemid 46028489)
8. Grimsley, C., and K. S. Ravichandran. 2003. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 13: 648-656. (Pubitemid 37415030)
9. Valko, M., M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser. 2004. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 266: 37-56. (Pubitemid 39562306)
10. Dean, R. T., S. Fu, R. Stocker, and M. J. Davies. 1997. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324: 1-18. (Pubitemid 27229359)
11. Cooke, M. S., M. D. Evans, M. Dizdaroglu, and J. Lunec. 2003. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17: 1195-1214. (Pubitemid 36775767)
12. Sambrano, G. R., and D. Steinberg. 1995. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA 92: 1396-1400.
13. Hazen, S. L., and G. M. Chisolm. 2002. Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response. Proc. Natl. Acad. Sci. USA 99: 12515-12517.
14. Hazen, S. L. 2008. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem. 283: 15527-15531.
15. Loiarro, M., C. Sette, G. Gallo, A. Ciacci, N. Fantò, D. Mastroianni, P. Carminati, and V. Ruggiero. 2005. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NFκB. J. Biol. Chem. 280: 15809-15814. (Pubitemid 40616701)
16. Chen, C. H., G. R. Budas, E. N. Churchill, M. H. Disatnik, T. D. Hurley, and D. Mochly-Rosen. 2008. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495.
17. Perez-Miller, S., H. Younus, R. Vanam, C. H. Chen, D. Mochly-Rosen, and T. D. Hurley. 2010. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat. Struct. Mol. Biol. 17: 159-164.
18. DeWitte-Orr, S. J., S. E. Collins, C. M. Bauer, D. M. Bowdish, and K. L. Mossman. 2010. An accessory to the "Trinity": SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog. 6: e1000829.
19. Malhotra, J. D., H. Miao, K. Zhang, A. Wolfson, S. Pennathur, S. W. Pipe, and R. J. Kaufman. 2008. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA 105: 18525-18530.
20. Niethammer, P., C. Grabher, A. T. Look, and T. J. Mitchison. 2009. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996-999.
21. Passlick, B., D. Flieger, and H. W. Ziegler-Heitbrock. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534. (Pubitemid 19286475)
22. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
23. Pugin, J., C. C. Schürer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748. (Pubitemid 23113493)
24. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1993. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178: 2193-2200. (Pubitemid 23344877)
25. Kitchens, R. L., and P. A. Thompson. 2005. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11: 225-229. (Pubitemid 41358857)
26. Re, F., and J. L. Strominger. 2003. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J. Immunol. 171: 5272-5276. (Pubitemid 37432812)
27. Kennedy, M. N., G. E. Mullen, C. A. Leifer, C. Lee, A. Mazzoni, K. N. Dileepan, and D. M. Segal. 2004. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J. Biol. Chem. 279: 34698-34704. (Pubitemid 39318100)
28. Suzuki, N., S. Suzuki, and W. C. Yeh. 2002. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol. 23: 503-506. (Pubitemid 35248046)
29. Kohen, R., and A. Nyska. 2002. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 30: 620-650. (Pubitemid 36018731)
30. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285: 732-736.
31. Manukyan, M., K. Triantafilou, M. Triantafilou, A. Mackie, N. Nilsen, T. Espevik, K. H. Wiesmüller, A. J. Ulmer, and H. Heine. 2005. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 35: 911-921. (Pubitemid 40425547)
32. Nakata, T., M. Yasuda, M. Fujita, H. Kataoka, K. Kiura, H. Sano, and K. Shibata. 2006. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 8: 1899-1909. (Pubitemid 44680872)
33. Dahl, M., A. K. Bauer, M. Arredouani, R. Soininen, K. Tryggvason, S. R. Kleeberger, and L. Kobzik. 2007. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J. Clin. Invest. 117: 757-764. (Pubitemid 46348534)
34. Bowdish, D. M., K. Sakamoto, M. J. Kim, M. Kroos, S. Mukhopadhyay, C. A. Leifer, K. Tryggvason, S. Gordon, and D. G. Russell. 2009. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 5: e1000474.
35. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
36. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009. (Pubitemid 24266467)
37. Leitinger, N. 2003. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14: 421-430. (Pubitemid 37297296)
38. Feige, E., I. Mendel, J. George, N. Yacov, and D. Harats. 2010. Modified phospholipids as anti-inflammatory compounds. Curr. Opin. Lipidol. 21: 525-529.
39. Krönke, G., V. N. Bochkov, J. Huber, F. Gruber, S. Blüml, A. Fürnkranz, A. Kadl, B. R. Binder, and N. Leitinger. 2003. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J. Biol. Chem. 278: 51006-51014. (Pubitemid 38020334)
40. Bochkov, V. N., A. Kadl, J. Huber, F. Gruber, B. R. Binder, and N. Leitinger. 2002. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419: 77-81. (Pubitemid 34987873)
41. Walton, K. A., A. L. Cole, M. Yeh, G. Subbanagounder, S. R. Krutzik, R. L. Modlin, R. M. Lucas, J. Nakai, E. J. Smart, D. K. Vora, et al. 2003. Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 23: 1197-1203. (Pubitemid 36871273)
42. Ma, Z., J. Li, L. Yang, Y. Mu, W. Xie, B. Pitt, and S. Li. 2004. Inhibition of LPS-and CpG DNA-induced TNF-α response by oxidized phospholipids. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L808-L816. (Pubitemid 38365067)
43. Blüml, S., S. Kirchberger, V. N. Bochkov, G. Krönke, K. Stuhlmeier, O. Majdic, G. J. Zlabinger, W. Knapp, B. R. Binder, J. Stöckl, and N. Leitinger. 2005. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J. Immunol. 175: 501-508. (Pubitemid 40884355)
44. Erridge, C., S. Kennedy, C. M. Spickett, and D. J. Webb. 2008. Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J. Biol. Chem. 283: 24748-24759.
45. Truman, L. A., C. A. Ogden, S. E. Howie, and C. D. Gregory. 2004. Macrophage chemotaxis to apoptotic Burkitt's lymphoma cells in vitro: role of CD14 and CD36. Immunobiology 209: 21-30. (Pubitemid 39255688)
46. Devitt, A., O. D. Moffatt, C. Raykundalia, J. D. Capra, D. L. Simmons, and C. D. Gregory. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505-509. (Pubitemid 28168983)
47. Cote, M., J. Drouin-Ouellet, F. Cicchetti, and D. Soulet. 2011. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity. Brain Behav. Immun. 25: 1143-1152.
48. Rieker, C., D. Engblom, G. Kreiner, A. Domanskyi, A. Schober, S. Stotz, M. Neumann, X. Yuan, I. Grummt, G. Schütz, and R. Parlato. 2011. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J. Neurosci. 31: 453-460.
49. Karlsson, M., M. Mandl, and S. M. Keyse. 2006. Spatio-temporal regulation of mitogen-activated protein kinase (MAPK) signalling by protein phosphatases. Biochem. Soc. Trans. 34(Pt. 5): 842-845. (Pubitemid 44796434)
50. Sanjuan, M. A., N. Rao, K. T. Lai, Y. Gu, S. Sun, A. Fuchs, W. P. Fung-Leung, M. Colonna, and L. Karlsson. 2006. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 172: 1057-1068.
51. Maa, M. C., M. Y. Chang, Y. J. Chen, C. H. Lin, C. J. Yu, Y. L. Yang, J. Li, P. R. Chen, C. H. Tang, H. Y. Lei, and T. H. Leu. 2008. Requirement of inducible nitric-oxide synthase in lipopolysaccharide-mediated Src induction and macrophage migration. J. Biol. Chem. 283: 31408-31416.
52. Maa, M. C., M. Y. Chang, J. Li, Y. Y. Li, M. Y. Hsieh, C. J. Yang, Y. J. Chen, Y. Li, H. C. Chen, W. E. Cheng, et al. 2011. The iNOS/Src/FAK axis is critical in Toll-like receptor-mediated cell motility in macrophages. Biochim. Biophys. Acta 1813: 136-147.
53. Lauber, K., E. Bohn, S. M. Kröber, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730. (Pubitemid 36724936)
54. Bowdish, D. M., and S. Gordon. 2009. Conserved domains of the class A scavenger receptors: evolution and function. Immunol. Rev. 227: 19-31.
55. Park, Y. M., M. Febbraio, and R. L. Silverstein. 2009. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119: 136-145.
56. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527. (Pubitemid 40204309)
57. Yu, B., E. Hailman, and S. D. Wright. 1997. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99: 315-324. (Pubitemid 27053990)